The DOI matches its Crossref record, with a small difference in title or year; 38 of the 38 references it cites were found in a registry or an index.
Omega 3 Fatty Acids and Cardiovascular Outcomes: Systematic Review and Meta-Analysis
Abstract
Background—: Early trials evaluating the effect of omega 3 fatty acids (ω-3 FA) reported benefits for mortality and cardiovascular events but recent larger studies trials have variable findings. We assessed the effects of ω-3 FA on cardiovascular and other important clinical outcomes. Methods and Results—: We searched MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials for all randomized studies using dietary supplements, dietary interventions, or both. The primary outcome was a composite of cardiovascular events (mostly myocardial infarction, stroke, and cardiovascular death). Secondary outcomes were arrhythmia, cerebrovascular events, hemorrhagic stroke, ischemic stroke, coronary revascularization, heart failure, total mortality, nonvascular mortality, and end-stage kidney disease. Twenty studies including 63030 participants were included. There was no overall effect of ω-3 FA on composite cardiovascular events (relative risk [RR]=0.96; 95% confidence interval [CI], 0.90–1.03; P =0.24) or on total mortality (RR=0.95; 95% CI, 0.86–1.04; P =0.28). ω-3 FA did protect against vascular death (RR=0.86; 95% CI, 0.75–0.99; P =0.03) but not coronary events (RR=0.86; 95% CI, 0.67–1.11; P =0.24). There was no effect on arrhythmia (RR=0.99; 95% CI, 0.85–1.16; P =0.92) or cerebrovascular events (RR=1.03; 95% CI, 0.92–1.16; P =0.59). Adverse events were more common in the treatment group than the placebo group (RR=1.18, 95% CI, 1.02–1.37; P =0.03), predominantly because of an excess of gastrointestinal side effects. Conclusions—: ω-3 FA may protect against vascular disease, but the evidence is not clear-cut, and any benefits are almost certainly not as great as previously believed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One meta-analysis included 63 030 subjects from 20 trials and reported no overall effect of omega-3 fatty acids on composite CV events { relative risk [RR] 0.96 [95% confidence interval (CI) 0.90, 1.02]; P ¼ 0.24 } or total mortality [RR 0.95 (95% Cl 0.86, 1.04); P ¼ 0.28].”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [285]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610
Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516
Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease
de Lorgeril, M., Renaud, S., Salen, P., Monjaud, I., Mamelle, N., Martin, J. L., Guidollet, J., Touboul, P., & Delaye, J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92580-1 · Cited by 2,122
(1999) · PubMed · Cited by 2,062
Fish Intake, Contaminants, and Human Health: Evaluating the Risks and the Benefits
Mozaffarian, D., & Rimm, E. B. (2006) · JAMA · doi:10.1001/jama.296.15.1885 · Cited by 1,966
GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61239-8 · Cited by 1,350
Wang, C., Harris, W. S., Chung, M., Lichtenstein, A. H., Balk, E. M., Kupelnick, B., Jordan, H. S., & Lau, J. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.1.5 · Cited by 980
n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
Kromhout, D., Giltay, E. J., & Geleijnse, J. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003603 · Cited by 936
Research works printed but not linked: 3
- 10.1001/archinternmed.2012.262 · DOI
- Woodward M. Epidemiology: Design and Data Analysis. 2nd ed. Boca Raton, FL: Chapman and Hall/CRC Press; 2005.
- 10.1136/bmj.315.7109.629 · DOI · Paper page
Cited by
Sorted by citations
Items 201–201 of 201
The Effects of Diet in Hyperlipidemia
Allevato, J. M., & Allevato, I. (2015) · Springer eBooks · doi:10.1007/978-3-319-11161-2_7
Metadata
- Authors
- Kotwal, S., Jun, M., Sullivan, D., Perkovic, V., & Neal, B.
- Affiliations
- The University of Sydney (AU)
- Venue
- Circulation: Cardiovascular Quality and Outcomes
- Published
- 2012-11
- Volume
- 5
- Issue
- 6
- Pages
- 808-818
- ISSN
- 1941-7705 (ISSN-L)
- 1941-7713
- OpenAlex
- W2038708549
- Cited by
- 201
- References
- 38
- Citations by year
- 2025: 3 · 2024: 7 · 2023: 6 · 2022: 5 · 2021: 8 · 2020: 9 · 2019: 14 · 2018: 21 · 2017: 30 · 2016: 20 · 2015: 29 · 2014: 27 · 2013: 20 · 2012: 1
- FWCI
- 22.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Cardiovascular Quality and Outcomes (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Aquaculture Nutrition and Growth
- Keywords
- omega-3 fatty acids, cardiovascular outcomes, cardiovascular mortality, myocardial infarction, stroke, vascular death, cardiac arrhythmias, cerebrovascular events, coronary revascularization, heart failure, end-stage renal disease, gastrointestinal adverse effects, dietary supplements, omega-3 supplementation
- MeSH terms
- Aged, Cardiovascular Agents, Cardiovascular Diseases, Female, Humans, Male, Middle Aged, Fatty Acids, Omega-3, Odds Ratio, Treatment Outcome, Evidence-Based Medicine, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
